Nchi: Ureno
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
atipamezole chlorohydrate 4.27 mg
Vetpharma Animal Health S.L
QV03AB90
Solution for injection
atipamezole
Cats, Dogs
2013-06-26
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ATIPAZOLE 5 mg/ml Solution for injection for dogs and cats [BE, BG, DE, HU, LT, LV, NL, PL, SI, UK] ANTIDORM 5 mg/ml Solution for injection for dogs and cats [ES, FR, IT, PT] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains: ACTIVE SUBSTANCE: Atipamezole ...................................................... 4.27 mg (as atipamezole hydrochloride 5.0 mg) EXCIPIENTS: Methyl parahydroxybenzoate (E 218)..............1.0 mg For a full list of excipients, see Section 6.1 3. PHARMACEUTICAL FORM Solution for Injection. Clear and colourless solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Atipamezole hydrochloride is a selective α2-antagonist and indicated for reversal of the sedative effects of medetomidine and dexmedetomidine in dogs and cats. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance or any other excipients. 2 Do not use in breeding animals. Do not use in animals suffering from hepatic or renal or cardiac diseases. See also section 4.7 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE i) Special precautions for use in animals After administration of the product, the animals should be allowed to rest in a quiet place. During the recovery phase, animals should not be left unattended. Make sure the animal has regained a normal swallowing reflex before any Soma hati kamili